World Journal of
Pharmaceutical and Life Sciences

EVALUATING FOR SPECIFIC THROMBIN INHIBITORS IN MUSHROOMS

Rupali Rajiv Kumar and Koosh Pranav Asher*

ABSTRACT

Thrombin is the key serine proteinase of the coagulation course and in this way an appropriate objective for hindrance of blood coagulation. Various pharmacologically dynamic optional metabolites from mushrooms have effectively been confined, along these lines giving the reasoning for evaluating for new thrombin inhibitors in mushrooms. In this examination, inhibitory exercises of mushroom removes on thrombin and trypsin were estimated utilizing the chromogenic substrates H-D-phenylalanine-L-pipecolyl-L-arginine-paranitroaniline dihydrochloride (S-2238) for thrombin and N-benzoyl-D, L-Arg-p-nitroanilide (BAPNA) for trypsin. The inhibitory exercises of extricates from 95 Basidiomycete species have been resolved. Most of tests hindered trypsin and thrombin with different potencies; be that as it may, a few concentrates showed no action against either of the chemicals. A fluid concentrate of Gleophyllum odoratum displayed high inhibitory action on both thrombin and trypsin (72 and 60%, individually), while concentrates of Clitocybe gibba, Amanita virosa, Cantharellus lutescens, Suillus tridentinus, Hypoloma fasciculare and Lactarius badiosanguineus significantly hindered thrombin (49, 48, 36, 34, 32 and 31%, individually) and showed no inhibitory movement on trypsin. The outcomes now are promising for additional exploration with the target of tracking down a compelling and safe thrombin inhibitor.

[Full Text Article]   [Download Certificate]